Eupraxia Pharmaceuticals Common Stock Buy Hold or Sell Recommendation
| EPRX Stock | 3.41 0.08 2.29% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Eupraxia Pharmaceuticals Common is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Eupraxia Pharmaceuticals Common given historical horizon and risk tolerance towards Eupraxia Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Eupraxia Pharmaceuticals Common, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. In addition, we conduct extensive research on individual companies such as Eupraxia and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Eupraxia Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Eupraxia |
Execute Eupraxia Pharmaceuticals Buy or Sell Advice
The Eupraxia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Eupraxia Pharmaceuticals Common. Macroaxis does not own or have any residual interests in Eupraxia Pharmaceuticals Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Eupraxia Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Eupraxia Pharmaceuticals Trading Alerts and Improvement Suggestions
| Eupraxia Pharmaceuticals is way too risky over 90 days horizon | |
| Eupraxia Pharmaceuticals appears to be risky and price may revert if volatility continues |
Eupraxia Pharmaceuticals Returns Distribution Density
The distribution of Eupraxia Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Eupraxia Pharmaceuticals' future price movements. The chart of the probability distribution of Eupraxia Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Eupraxia Pharmaceuticals Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Eupraxia Pharmaceuticals returns is essential to provide solid investment advice for Eupraxia Pharmaceuticals.
| Mean Return | 0.57 | Value At Risk | -6.39 | Potential Upside | 7.93 | Standard Deviation | 5.07 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Eupraxia Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Eupraxia Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Eupraxia Pharmaceuticals or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Eupraxia Pharmaceuticals' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Eupraxia pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.63 | |
β | Beta against Dow Jones | -0.62 | |
σ | Overall volatility | 5.11 | |
Ir | Information ratio | 0.09 |
Eupraxia Pharmaceuticals Volatility Alert
Eupraxia Pharmaceuticals Common shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Eupraxia Pharmaceuticals' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Eupraxia Pharmaceuticals' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Eupraxia Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Eupraxia . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Use Investing Ideas to Build Portfolios
In addition to having Eupraxia Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Eupraxia Pink Sheet Analysis
When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.